Jpmorgan Chase & CO Optimize Rx Corp Transaction History

Jpmorgan Chase & CO

$1.1 Trillion
Q1 2024

A detailed history of Jpmorgan Chase & CO transactions in Optimize Rx Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 139,048 shares of OPRX stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

139,048

Previous 126,896 9.58%

Holding current value

$1.39 Million

Previous $1.82 Million 6.94%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$11.47 - $16.17 $139,383 - $196,497	12,152 Added 9.58%	139,048 $1.69 Million
Q4 2023 Feb 12, 2024	BUY	$7.06 - $14.49 $14,070 - $28,878	1,993 Added 1.6%	126,896 $1.82 Million
Q3 2023 Nov 14, 2023	SELL	$7.43 - $14.96 $71,476 - $143,915	-9,620 Reduced 7.15%	124,903 $971,000
Q2 2023 Aug 11, 2023	SELL	$11.63 - $15.63 $75,071 - $100,891	-6,455 Reduced 4.58%	134,523 $1.92 Million
Q1 2023 May 18, 2023	BUY	$12.54 - $19.38 $160,524 - $248,083	12,801 Added 9.99%	140,978 $2.06 Million

Q1 2023 May 11, 2023	SELL	$12.54 - $19.38 $187,071 - $289,110	-14,918 Reduced 10.43%	128,177 $1.88 Million
Q4 2022 Feb 13, 2023	BUY	$13.77 - $22.04 $1.84 Million - $2.94 Million	133,358 Added 1369.6%	143,095 $2.4 Million
Q3 2022 Nov 14, 2022	BUY	$13.74 - $30.13 $2,857 - $6,267	208 Added 2.18%	9,737 $144,000
Q2 2022 Aug 11, 2022	SELL	$21.94 - $40.49 $81,309 - $150,055	-3,706 Reduced 28.0%	9,529 $261,000
Q1 2022 May 11, 2022	BUY	$35.27 - $62.91 $67,718 - $120,787	1,920 Added 16.97%	13,235 $499,000
Q4 2021 Feb 10, 2022	BUY	$53.57 - $98.0 $257,564 - $471,184	4,808 Added 73.89%	11,315 $702,000
Q3 2021 Nov 12, 2021	BUY	$50.93 - $85.55 $331,401 - $556,673	6,507 New	6,507 $556,000

Others Institutions Holding OPRX

# of Institutions

101

Shares Held

12.9M

Call Options Held

18.6K

Put Options Held

1.1K

View Full List

About OptimizeRx Corp

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $180M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

More about OPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Optimize Rx Corp Transaction History